What is the Difference Between Carcinoid Tumor and Carcinoid Syndrome?

🆚 Go to Comparative Table 🆚

Carcinoid tumors and carcinoid syndrome are related but distinct entities. Here are the main differences between the two:

  1. Carcinoid tumors are slow-growing, rare cancers that originate in the neuroendocrine system, which produces hormones. They usually grow in the gastrointestinal tract, such as the bowels, appendix, stomach, or pancreas, but can also be found in the lung, breast, kidney, ovaries, or testicles. These tumors can produce hormones and chemicals, but not all carcinoid tumors cause symptoms.
  2. Carcinoid syndrome occurs when carcinoid tumors, usually in the gastrointestinal tract, produce large quantities of hormones, such as serotonin, causing symptoms. Fewer than 10% of people with carcinoid tumors develop carcinoid syndrome. The classic "carcinoid triad" associated with the syndrome includes flushing, diarrhea, and cardiac involvement. Treatment for carcinoid syndrome often involves managing the symptoms through medications like octreotide and lanreotide.

In summary, carcinoid tumors are slow-growing, rare cancers that can produce hormones, while carcinoid syndrome is a collection of symptoms that occur when these tumors produce excessive amounts of hormones.

Comparative Table: Carcinoid Tumor vs Carcinoid Syndrome

Carcinoid tumors and carcinoid syndrome are related but distinct conditions. Here is a table summarizing their differences:

Feature Carcinoid Tumors Carcinoid Syndrome
Definition Carcinoid tumors are rare, slow-growing neuroendocrine tumors that originate in the hormone-producing cells of various organs, such as the gastrointestinal tract, lungs, pancreas, and ovaries. Carcinoid syndrome is a paraneoplastic syndrome caused by the release of serotonin and other hormone-like substances from carcinoid tumors.
Symptoms Symptoms of carcinoid tumors are mainly cramping pain and changes in bowel movements as a result of the tumor. The hallmark symptoms of carcinoid syndrome are flushing and diarrhea. Atypical signs and symptoms can include wheezing, abdominal pain, valvular heart disease, telangiectasias, pellagra, and complications of mesenteric fibrosis.
Prevalence Carcinoid tumors can be found in various organs, including the gastrointestinal tract, lungs, pancreas, and ovaries. Fewer than 10% of people with carcinoid tumors develop symptoms of carcinoid syndrome. Carcinoid syndrome predominantly arises in neuroendocrine tumors of midgut origin, such as the jejunum, ileum, cecum, and ascending colon. It can also be encountered in bronchial neuroendocrine tumors or ovarian, pancreatic, and unknown primary tumors.
Diagnosis Diagnosis of carcinoid tumors involves imaging tests and measurement of the amount of a serotonin byproduct in a person's urine. Diagnosis of carcinoid syndrome is based on clinical and laboratory findings, with ancillary roles for imaging.
Treatment Treatment options for carcinoid tumors may include surgery and medical management. Treatment options for carcinoid syndrome include surgery, medical management with somatostatin analogs, and managing symptoms with medication.

It is important to note that not all carcinoid tumors cause carcinoid syndrome. However, when carcinoid syndrome is present, it is often a sign that the tumor has spread beyond locoregional disease, such as in the case of liver metastases.